학술논문
The European Renal Association--European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary
ORIGINAL ARTICLE
ORIGINAL ARTICLE
Document Type
Report
Author
Kramer, Anneke; Pippias, Maria; Noordzij, Marlies; Stel, Vianda S.; Andrusev, Anton M.; Aparicio-Madre, Manuel I.; Monzon, Federico E. Arribas; Asberg, Anders; Barbullushi, Myftar; Beltran, Palma; Bonthuis, Marjolein; Caskey, Fergus J.; de la Nuez, Pablo Castro; Cernevskis, Harijs; de Meester, Johan; Finne, Patrik; Golan, Eliezer; Heaf, James G.; Hemmelder, Marc H.; Ioannou, Kyriakos; Kantaria, Nino; Komissarov, Kirill; Korejwo, Grzegorz; Kramar, Reinhard; Lassalle, Mathilde; Lopot, Frantisek; MacArio, Fernando; MacKinnon, Bruce; Palsson, Runolfur; Pechter, Ulle; Pinera, Vicente C.; de Pablos, Carmen Santiuste; Segarra-Medrano, Alfons; Seyahi, Nurhan; Roblero, Maria F. Slon; Stojceva-Taneva, Olivera; Vazelov, Evgueniy; Winzeler, Rebecca; Ziginskiene, Edita; Massy, Ziad; Jager, Kitty J.
Source
Clinical Kidney Journal. October 2019, Vol. 12 Issue 5, p702, 19 p.
Subject
Language
English
ISSN
2048-8505
Abstract
INTRODUCTION The European Renal Association--European Dialysis and Transplant Association (ERA-EDTA) Registry's Annual Report describes the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) within Europe and countries [...]
Background. This article summarizes the ERA-EDTA Registry's 2016 Annual Report, by describing the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in 2016 within 36 countries. Methods. In 2017 and 2018, the ERA-EDTA Registry received data on patients undergoing RRT for ESRD in 2016 from 52 national or regional renal registries. In all, 32 registries provided individual patient data and 20 provided aggregated data. The incidence and prevalence of RRT and the survival probabilities of these patients were determined. Results. In 2016, the incidence of RRT for ESRD was 121 per million population (pmp), ranging from 29 pmp in Ukraine to 251 pmp in Greece. Almost two-thirds of patients were men, over half were aged [greater than or equal to]65 years and almost a quarter had diabetes mellitus as their primary renal diagnosis. Treatment modality at the start of RRT was haemodialysis for 84% of patients. On 31 December 2016, the prevalence of RRT was 823 pmp, ranging from 188 pmp in Ukraine to 1906 pmp in Portugal. In 2016, the transplant rate was 32 pmp, varying from 3 pmp in Ukraine to 94 pmp in the Spanish region of Catalonia. For patients commencing RRT during 2007-11, the 5-year unadjusted patient survival probability on all RRT modalities combined was 50.5%. For 2016, the incidence and prevalence of RRT were higher among men (187 and 1381 pmp) than women (101 and 827 pmp), and men had a higher rate of kidney transplantation (59 pmp) compared with women (33 pmp). For patients starting dialysis and for patients receiving a kidney transplant during 2007-11, the adjusted patient survival probabilities appeared to be higher for women than for men. Keywords: dialysis, end-stage renal disease, epidemiology, kidney transplantation, survival analysis
Background. This article summarizes the ERA-EDTA Registry's 2016 Annual Report, by describing the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in 2016 within 36 countries. Methods. In 2017 and 2018, the ERA-EDTA Registry received data on patients undergoing RRT for ESRD in 2016 from 52 national or regional renal registries. In all, 32 registries provided individual patient data and 20 provided aggregated data. The incidence and prevalence of RRT and the survival probabilities of these patients were determined. Results. In 2016, the incidence of RRT for ESRD was 121 per million population (pmp), ranging from 29 pmp in Ukraine to 251 pmp in Greece. Almost two-thirds of patients were men, over half were aged [greater than or equal to]65 years and almost a quarter had diabetes mellitus as their primary renal diagnosis. Treatment modality at the start of RRT was haemodialysis for 84% of patients. On 31 December 2016, the prevalence of RRT was 823 pmp, ranging from 188 pmp in Ukraine to 1906 pmp in Portugal. In 2016, the transplant rate was 32 pmp, varying from 3 pmp in Ukraine to 94 pmp in the Spanish region of Catalonia. For patients commencing RRT during 2007-11, the 5-year unadjusted patient survival probability on all RRT modalities combined was 50.5%. For 2016, the incidence and prevalence of RRT were higher among men (187 and 1381 pmp) than women (101 and 827 pmp), and men had a higher rate of kidney transplantation (59 pmp) compared with women (33 pmp). For patients starting dialysis and for patients receiving a kidney transplant during 2007-11, the adjusted patient survival probabilities appeared to be higher for women than for men. Keywords: dialysis, end-stage renal disease, epidemiology, kidney transplantation, survival analysis